Table 1 (abstract P232). See text for description
From: Proceedings of the 28th European Paediatric Rheumatology Congress (PReS 2022)
| Â | Baseline | Follow-up | ||||
|---|---|---|---|---|---|---|
JIA | SLE | JDM | JIA | SLE | JDM | |
Glucocorticoids systemically, % | 17 | 63 | 60 | 6 | 69 | 60 |
DMARD, % | 33 | 63 | 50 | 64 | 88 | 70 |
Overall well-being (NRS 0-10) | 4.0 | 4.4 | 6.1 | 1.9 | 3.1 | 2.5 |
Pain (NRS 0-10) | 3.5 | 3.7 | 4.8 | 1.6 | 2.8 | 2.2 |
Fatigue (NRS 0-10) | 3.0 | 4.9 | 5.4 | 1.6 | 3.4 | 2.5 |
Coping with illness (NRS 0-10, 0 = very good) | 3.5 | 4.2 | 5.6 | 1.3 | 2.9 | 1.5 |
PedsQL 4.0 (total score 0-100) | 70.2 | 62.9 | 48.7 | 82.3 | 76.0 | 74.1 |